Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci

Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Trends in Pharmacological Sciences (Impact Factor: 11.54). 01/2012; 33(1):17-27. DOI: 10.1016/
Source: PubMed


G protein-coupled receptors (GPCRs) comprise the most 'prolific' family of cell membrane proteins, which share a general mechanism of signal transduction, but greatly vary in ligand recognition and function. Crystal structures are now available for rhodopsin, adrenergic, and adenosine receptors in both inactive and activated forms, as well as for chemokine, dopamine, and histamine receptors in inactive conformations. Here we review common structural features, outline the scope of structural diversity of GPCRs at different levels of homology, and briefly discuss the impact of the structures on drug discovery. Given the current set of GPCR crystal structures, a distinct modularity is now being observed between the extracellular (ligand-binding) and intracellular (signaling) regions. The rapidly expanding repertoire of GPCR structures provides a solid framework for experimental and molecular modeling studies, and helps to chart a roadmap for comprehensive structural coverage of the whole superfamily and an understanding of GPCR biological and therapeutic mechanisms.

Download full-text


Available from: Vsevolod Katritch, Feb 20, 2015
  • Source
    • "G protein-coupled receptors (GPCR) are the targets for more than 25% of currently available drugs[1]and represent 15% of the " druggable genome "[2]. Advances in our understanding of GPCR structure and function will continue to elucidate their roles in basic biology and inform GPCR-directed drug discovery projects[3,4]. Experimental methods based on surface plasmon resonance (SPR) have been used to study protein-protein interactions of GPCR and their associated signaling machinery567. "

    Preview · Article · Jan 2016
  • Source
    • "In this study, helix VI and helix VII were found to move independently, providing a physical basis for biased agonism and a conformational "signature" predictive of arrestin selectivity. Although to date there is little direct X-ray crystallographic structure of GPCRs bound to conventional and biased agonist ligands, computational modeling of agonist docking within the ligand binding pocket of family A GPCRs suggests that efficacy correlates with engagement of certain residues and exclusion of interaction with others (Katritch et al., 2012; Jacobson and Costanzi, 2012; Costanzi, 2014). Historically, the experimental hallmark of orthosteric ligand bias has been "reversal of potency," where two ligands exhibit opposite rank order of potency for two downstream responses measured in the same system (Sagan et al., 1996; Berg et al., 1998; Takasu et al., 1999), or "reversal of efficacy," where a single ligand exhibits opposing efficacy toward two "

    Full-text · Dataset · Sep 2015
  • Source
    • "An understanding of the function of a membrane receptor starts with determination of its structure and the nature of its ligand-binding site. Impressive advances have been made in the last decade in membrane protein expression and purification resulting in the use of X-ray crystallography on membrane protein crystals of G protein-coupled receptors (GPCRs) to elucidate overall structure, and in some cases, an atomic-level image of the ligand-binding site (Bortolato et al., 2014; Cherezov et al., 2007; Chien et al., 2010; Chung et al., 2011; Hanson & Stevens, 2009; Jaakola et al., 2008; Katritch, Cherezov, & Stevens, 2012; Rasmussen et al., 2011; Scheerer et al., 2009; Warne et al., 2008, 2011; Wu et al., 2010, 2014). Approximately, 360 genes encode members of a human membrane protein family composed of nonolfactory GPCRs (Fredriksson, Lagerstrom, Lundin, & Schioth, 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Experiments are described that allowed cross-linking of analogs of a 13-amino acid peptide into the binding site of a model G protein-coupled receptor. Syntheses of peptide analogs that were used for photochemical or chemical cross-linking were carried out using solid-phase peptide synthesis. Chemical cross-linking utilized 3,4-dihydroxy-l-phenylalanine-incorporated peptides and subsequent periodate-mediated activation, whereas photochemical cross-linking was mediated by p-benzoyl-l-phenylalanine (Bpa)-labeled peptides and UV-initiated activation. Mass spectrometry was employed to locate the site(s) in the receptor that formed the cross-links to the ligand. We also describe a method called unnatural amino acid replacement that allowed capture of a peptide ligand into the receptor. In this method, the receptor was genetically modified by replacement of a natural amino acid with Bpa. The modified receptor was UV-irradiated to capture the ligand. The approaches described are applicable to other peptide-binding proteins and can reveal the ligand-binding site in atomic detail. © 2015 Elsevier Inc. All rights reserved.
    Full-text · Article · Apr 2015 · Methods in enzymology
Show more